Skip to content

Rapitex RF New

by Behring Diagnostics, Inc. 510(k)

Active United States

510(k) K903852

Regulatory status

as of 28 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK903852 Date30 Aug 1990ClearedStatusActive

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 22 Oct 2026.

Specification

510(k)

Full name
Rapitex(R) Rf New
510(k) Number
FDA Product Code
DHR
Device Class
Class II
Regulation
21 CFR Part 866.5775
Advisory Committee
Immunology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 25 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

This device is a system test for rheumatoid factor, classified under product code DHR and medical specialty Immunology. It is a Class II device subject to special controls, as indicated by its FDA 510(k) clearance.

The device was cleared by the FDA via the traditional 510(k) pathway on August 30, 1990, under K903852, following submission by Behring Diagnostics, Inc. It is substantially equivalent to a predicate device and is authorized for distribution in the United States.

Other devices from Behring Diagnostics, Inc.

See all devices from Behring Diagnostics, Inc. →

Questions

AI-generated answers, 25 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the RAPITEX(R) RF NEW device used for?

    The RAPITEX(R) RF NEW is a system test designed to detect rheumatoid factor in patient samples, used within the field of immunology to assist in the diagnosis and monitoring of rheumatoid arthritis and related autoimmune conditions.

  • How is the RAPITEX(R) RF NEW device supplied and what is its regulatory status?

    The device is supplied as a diagnostic test system for laboratory use and received FDA 510(k) clearance through the traditional pathway on August 30, 1990, under K903852, confirming it is substantially equivalent to a legally marketed predicate device.

  • What classification and product code apply to the RAPITEX(R) RF NEW device?

    RAPITEX(R) RF NEW is classified as a Class II medical device under product code DHR, which corresponds to system tests for rheumatoid factor, and is subject to special controls as required by its classification.